BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7637822)

  • 21. [The antitumor activity of Diosgenin in vivo and in vitro].
    Wang LJ; Wang Y; Chen SW; Ma JS; Fu Q; Wang BX
    Zhongguo Zhong Yao Za Zhi; 2002 Oct; 27(10):777-9. PubMed ID: 12776562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen.
    Yip KW; Mao X; Au PY; Hedley DW; Chow S; Dalili S; Mocanu JD; Bastianutto C; Schimmer A; Liu FF
    Clin Cancer Res; 2006 Sep; 12(18):5557-69. PubMed ID: 17000693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
    Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cytotoxicity of methyl protoneogracillin (NSC-698793) and gracillin (NSC-698787), two steroidal saponins from the rhizomes of Dioscorea collettii var. hypoglauca, against human cancer cells in vitro.
    Hu K; Yao X
    Phytother Res; 2003 Jun; 17(6):620-6. PubMed ID: 12820229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
    Zhang Q; Pan J; Zheng RL; Wang Q
    Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antineoplastic and cytotoxic activity of beta-alkylamino-(para-substituted)propiophenone and beta-alkylamino-(6-methyl)-naphthone derivatives in murine and human tissue culture cells.
    Huang Y; Hall IH
    Pharmazie; 1998 Feb; 53(2):117-23. PubMed ID: 9540108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
    Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity and oncostatic activity of the thiazolidinedione derivative CGP 52608 on central nervous system cancer cells.
    Herrera F; Mayo JC; Martín V; Sainz RM; Antolin I; Rodriguez C
    Cancer Lett; 2004 Jul; 211(1):47-55. PubMed ID: 15194216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
    Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
    J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antitumor evaluation, molecular modeling and quantitative structure-activity relationship (QSAR) of some novel arylazopyrazolodiazine and triazine analogs.
    El-Shafei A; Fadda AA; Khalil AM; Ameen TA; Badria FA
    Bioorg Med Chem; 2009 Jul; 17(14):5096-105. PubMed ID: 19527933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
    Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
    Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
    El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
    Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumor effect of synthetic cord factor analogue, 6, 6'-Di-O-decanoyl-alpha, alpha-trehalose].
    Ishii F; Takano S; Kohya H; Ishida N
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1629-34. PubMed ID: 6548105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antiproliferative effect of N-(alkyladamantyl)phthalimides in vitro.
    Horvat M; Uzelac L; Marjanović M; Cindro N; Franković O; Mlinarić-Majerski K; Kralj M; Basarić N
    Chem Biol Drug Des; 2012 Apr; 79(4):497-506. PubMed ID: 22176512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
    Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
    J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and antitumor activity evaluation of 1-[(arylidene)amino]adamantanes.
    Chimirri A; Gitto R; Grasso S; Monforte AM; Zappalà M
    Farmaco; 1994 Oct; 49(10):649-51. PubMed ID: 7826471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapeutic potential of the volatile oils from Zanthoxylum rhoifolium Lam leaves.
    da Silva SL; Figueiredo PM; Yano T
    Eur J Pharmacol; 2007 Dec; 576(1-3):180-8. PubMed ID: 17716654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.